Domů › Rakovina endometria › Minnesota › Minneapolis
Klinické studie Rakovina endometria v Minneapolis, MN
18 studií pro Rakovina endometria hledá účastníky v lokalitách v Minneapolis a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · Vzdálenost 5 mi
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Probíhá náborFáze 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · Vzdálenost 5 mi
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · Vzdálenost 5 mi
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Probíhá náborFáze 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · Vzdálenost 5 mi
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Probíhá náborFáze 3
- Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Probíhá náborFáze 3
- USOR - Minnesota Oncology/ Minneapolis Clinic, Minneapolis
- USOR - Minnesota Oncology, Minneapolis
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Probíhá náborFáze 3
- Research Site, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Probíhá náborFáze 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Probíhá náborFáze 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Probíhá náborFáze 1
- Normunity Investigational Site, Minneapolis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Probíhá náborFáze 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Probíhá náborFáze 3
- Research Site, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Probíhá náborFáze 2
- 518, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Probíhá náborFáze 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Allina Health Cancer Institute, Minneapolis
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Probíhá náborFáze 2/3
- Minnesota Oncology Hematology, P.A., Minneapolis
Studie Rakovina endometria v jiných městech
- Houston, TX68 studií
- New York City, NY52 studií
- Boston, MA50 studií
- Arlington, VA39 studií
- Nashville, TN38 studií
- Los Angeles, CA34 studií
- St. Louis, MO29 studií
- Philadelphia, PA28 studií
- San Antonio, TX27 studií
- Chicago, IL25 studií
- Columbus, OH25 studií
- Queens, NY25 studií
Další studie v Minneapolis
- Rakovina prsu27 studií
- Nemalobuněčný plicní karcinom26 studií
- Rakovina vaječníků24 studií
- Rakovina prostaty23 studií
- Rakovina (všechny typy)22 studií
- Srdeční selhání21 studií
- Rakovina plic20 studií
- Akutní myeloidní leukemie20 studií
- Kolorektální karcinom19 studií
- Parkinsonova choroba17 studií
- Kardiovaskulární onemocnění15 studií
- Koronární onemocnění srdce13 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.